ADCY3 Protein — Adenylate Cyclase 3
Overview
Adenylate cyclase 3 (ADCY3) is a membrane-bound enzyme that catalyzes the synthesis of cyclic adenosine monophosphate (cAMP), a critical second messenger molecule in cellular signaling. Encoded by the ADCY3 gene located on chromosome 2, ADCY3 is predominantly expressed in neurons, particularly within the olfactory epithelium, striatum, and other regions of the central and peripheral nervous systems. As one of the ten mammalian adenylate cyclase isoforms (ADCY1-10), ADCY3 is uniquely positioned as a calcium-calmodulin-regulated cyclase, making it a key regulator of neuronal excitability and synaptic plasticity. The protein is an integral membrane protein with twelve transmembrane domains, characteristic of adenylate cyclase family members, with dual catalytic domains positioned on the intracellular side of the plasma membrane.
Function and Biology
...ADCY3 Protein — Adenylate Cyclase 3
Overview
Adenylate cyclase 3 (ADCY3) is a membrane-bound enzyme that catalyzes the synthesis of cyclic adenosine monophosphate (cAMP), a critical second messenger molecule in cellular signaling. Encoded by the ADCY3 gene located on chromosome 2, ADCY3 is predominantly expressed in neurons, particularly within the olfactory epithelium, striatum, and other regions of the central and peripheral nervous systems. As one of the ten mammalian adenylate cyclase isoforms (ADCY1-10), ADCY3 is uniquely positioned as a calcium-calmodulin-regulated cyclase, making it a key regulator of neuronal excitability and synaptic plasticity. The protein is an integral membrane protein with twelve transmembrane domains, characteristic of adenylate cyclase family members, with dual catalytic domains positioned on the intracellular side of the plasma membrane.
Function and Biology
ADCY3 functions as a molecular integrator of cellular signals by converting adenosine triphosphate (ATP) to cAMP in response to G-protein coupled receptor (GPCR) activation. Upon GPCR stimulation, heterotrimeric G proteins (particularly Gs and Gi/o proteins) interact with ADCY3's regulatory domains, either enhancing or inhibiting its enzymatic activity depending on the specific G-protein subtype engaged. A distinctive feature of ADCY3 is its direct responsiveness to calcium-calmodulin complexes, which can either activate or inhibit the enzyme depending on calmodulin binding domain interactions and the cellular context. This calcium sensitivity makes ADCY3 particularly important in neurons where calcium dynamics are closely linked to synaptic transmission and neuronal excitability.
The cAMP produced by ADCY3 activates protein kinase A (PKA) and other cAMP-responsive effectors, triggering downstream phosphorylation cascades that regulate gene expression, enzyme activity, and ion channel function. ADCY3 is particularly enriched in the striatum, where dopaminergic signaling is critical for motor control, and in the olfactory system, where it contributes to odorant detection and signal amplification.
Role in Neurodegeneration
ADCY3 dysfunction has emerged as a potential contributor to multiple neurodegenerative conditions. In Parkinson's disease, ADCY3 expression is altered in striatal medium spiny neurons, potentially disrupting dopamine-mediated motor signaling. The enzyme's role in cAMP-dependent protein kinase signaling cascades makes it relevant to the pathogenic mechanisms underlying aberrant neuronal firing patterns characteristic of Parkinson's disease. Genetic variants in ADCY3 have been associated with susceptibility to neurodegenerative diseases in genome-wide association studies, though the precise mechanistic contributions remain under investigation.
In Huntington's disease, altered cAMP signaling has been implicated in the selective vulnerability of medium spiny neurons expressing D2 dopamine receptors. ADCY3's involvement in this signaling pathway suggests potential pathogenic contributions to the motor and cognitive symptoms characteristic of this condition. Additionally, impaired cAMP-dependent neuroprotective signaling through reduced ADCY3 activity could compromise neuronal survival mechanisms in the face of mutant huntingtin protein toxicity.
Molecular Mechanisms
ADCY3-mediated neurodegeneration likely involves multiple converging mechanisms. Dysregulated cAMP production affects protein kinase A-dependent phosphorylation of critical substrates, including the cAMP response element binding protein (CREB), which regulates neurotrophic factor expression and neuroprotective gene programs. Impaired ADCY3 signaling may compromise cAMP-dependent inhibition of GSK-3β, leading to increased tau phosphorylation and amyloid-beta processing relevant to Alzheimer's disease pathology.
Calcium-mediated dysregulation of ADCY3 during excitotoxic conditions could further exacerbate neuronal damage through uncontrolled second messenger production or depletion. Mitochondrial dysfunction, characterized by impaired energy metabolism and oxidative stress, may be amplified through ADCY3-dependent signaling disruptions affecting mitochondrial calcium handling and bioenergetic processes.
Clinical and Research Significance
ADCY3 represents a potential therapeutic target for neuroprotective interventions. Pharmacological modulation of ADCY3 activity could enhance cAMP-dependent neuroprotection in neurodegeneration. Research into ADCY3 biology has expanded understanding of striatal-dependent movement disorders and may inform development of disease-modifying treatments for Parkinson's and Huntington's diseases.
- ADCY1, ADCY5, ADCY6, ADCY8, ADCY9 — Other adenylate cyclase isoforms with distinct tissue distributions and regulatory properties
- cAMP signaling pathway — Second messenger system downstream of ADCY3
- Dopamine receptors (D1, D2) — GPCR partners regulating ADCY3 activity
- Protein Kinase A (PKA)
AlphaFold Structure
AlphaFold DB provides a predicted structure for ADCY3 / UniProt O60266 (model version 6): https://alphafold.ebi.ac.uk/entry/O60266.
AlphaFold reports a mean pLDDT confidence score of 76.38, indicating confident backbone placement for much of the model, with lower-confidence regions possible.
InterPro annotations highlight Adenylyl cyclase class-3/4/guanylyl cyclase domain (270-472); Adenylyl cyclase class-4/guanylyl cyclase, conserved site conserved site (423-446); Nucleotide cyclase homologous superfamily (263-496).
PDB coordinates: https://alphafold.ebi.ac.uk/files/AF-O60266-F1-model_v6.pdb mmCIF coordinates: https://alphafold.ebi.ac.uk/files/AF-O60266-F1-model_v6.cif.
Use the prediction as structural context for target assessment; local low-pLDDT segments may reflect disorder, flexible linkers, or unresolved domain orientation rather than a stable fold.